St. Jude Medical, Inc.

NYSE: STJ
$80.82
+$0.00 (+0.0%)
Closing price January 18, 2017
St. Jude Medical has issued a press release aimed at responding to points in the Muddy Waters report, and a Credit Suisse research report has dispelled some of the concerns.
Jon C. Ogg
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Baidu, Boeing, Coeur Mining, Flextronics, NXP Semiconductors, Walt Disney and WebMD.
Jon C. Ogg
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Bats Global Markets, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer and SolarCity.
Jon C. Ogg
Stocks tanked on Friday but were indicated sharply higher on Tuesday after the three-day weekend and after China’s gross domestic product met expectations. While investors may feel that every...
Jon C. Ogg
Monday's top analyst upgrades, downgrades and initiations include AutoZone, Discover Financial Services, IBM, Microsoft, Twitter, Viacom and Wynn Resorts.
Jon C. Ogg
Thursday's top analyst upgrades, downgrades and initiations include Boeing, EMC, Hertz, Qualcomm, SanDisk, Twitter and XOMA.
Jon C. Ogg
Both companies announced the approval for a definitive agreement in which St. Jude Medical will acquire Thoratec in a cash transaction valued at roughly $3.4 billion.
Chris Lange
Wednesday's top analyst upgrades, downgrades and initiations include Enphase Energy, Harley-Davidson, Salesforce.com, Tesla Motors and World Wrestling Entertainment.
Jon C. Ogg
Thursday's top analyst upgrades, downgrades and initiations include JetBlue Airways, Salesforce.com, Staples, Whiting Petroleum and Yelp.
Jon C. Ogg
Thursday's top analyst upgrades, downgrades and initiations include Barrick Gold, Facebook, Halcon Resources, Qualcomm, Synchrony Financial and Texas Instruments.
Jon C. Ogg
Monday's top analyst upgrades, downgrades and initiations include Apple, BP, Hewlett-Packard, Philip Morris, UnitedHealth and AT&T.
Jon C. Ogg
Wednesday's top analyst upgrades and downgrades include Apple, Esperion Therapeutics, MercadoLibre, Oracle and Pandora Media.
Jon C. Ogg
Merrill Lynch analysts have added BlackRock and retained Citigroup on the firm's prized US 1 list.
Lee Jackson
Oppenheimer has released its list of potential post-election winners in the medical device industry.
Chris Lange
A new addition to the Merrill Lynch U.S.1 list prompted us to review their top stocks to buy, and they are not the same old monkey-see, monkey-do ideas that are so common on Wall Street.
Lee Jackson